Editor's note: On July 17, 2018, this story was updated to include additional information on the drug's indication as well as contraindications with other drugs. PRAC first noted concerns about this ...
Improving quality of health-related quality of life (HRQOL) reporting in phase III randomized controlled trials (RCTs) of metastatic prostate cancer (mPC). This is an ASCO Meeting Abstract from the ...
Oslo, Norway, 20 June 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, today celebrates the official opening of its commercial production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback